Bathi operasional sadurunge amortisasi: Lantern Pharma Inc. (LTRN)

Lantern Pharma Inc. (LTRN) is expanding its presence in oncotherapy by leveraging the RADR AI system to advance the LP-300 drug. The absolute EBITDA level correlates with these ambitions, with the 0.00 metric serving as the target level. Success is based on patent protection and test results, while financial stability relies on the calculated use of existing reserves to validate new compounds.

LTRN Bathi operasional EBITDA Lantern Pharma (23.11.2025 - 12.11.2026)

Ringkesan rincian data analitis Lantern Pharma (LTRN)

- rega pasar lan target rega analis:

Rega saham Lantern Pharma Inc|LTRN - Bagan rega target

- indikator kapitalisasi bursa perusahaan:

Kapitalisasi pasar Lantern Pharma|LTRN - Nilai Perusahaan

- indikator nilai aset resik miturut neraca:

Nilai Akuntansi saben Saham Lantern Pharma|LTRN - Kapitalisasi Buku|Koefisien Nilai Pasar marang Nilai Buku lanternpharma.com|LTRN - Aset Agregat Perusahaan

- rincian struktur utang lan likuiditas bisnis:

Rasio Kabeh Utang marang Dana Pribadi Lantern Pharma Inc.|LTRN - Utang jangka dawa marang ekuitas|Utang jangka cendhak marang ekuitas Lantern Pharma Inc|LTRN - Gunggung utang perusahaan|Utang-utang marang kapitalisasi buku Lantern Pharma|LTRN - Utang jangka dawa perusahaan|Tanggungan utang jangka cendhak perusahaan Lantern Pharma|Rasio likuiditas perantara lanternpharma.com

- data bathi lan kelipatan valuasi:

LTRN - Bathi resik|Bathi resik sing dikarepake Lantern Pharma Inc.|LTRN - Rasio rega marang bathi|Pangali mangsa ngarep rega marang bathi Lantern Pharma Inc|LTRN - Rasio rega marang bathi tumrap wutah|Nilai perusahaan marang bathi operasional sadurunge panyusutan Lantern Pharma|LTRN - Bathi operasional sadurunge ngurangi amortisasi|Bathi saben saham sajroning taun lumaku Lantern Pharma|LTRN - Bathi saben saham sajrone rolas wulan pungkasan|Dinamika bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan lanternpharma.com|LTRN - Wutah bathi ing taun lumaku|Dinamika bathi saben saham sing diarepake ing taun ngarep Lantern Pharma Inc.

Ringkesan analitik perusahaan:LTRN (Lantern Pharma Inc.)

Absolute operating profit before interest and taxes measures the actual cash flow from core operations, excluding the impact of debt load and tax regimes to assess the scale of the business. By analyzing the absolute EBITDA trend, an investor determines the effectiveness of the Lantern Pharma Inc. (LTRN) AI platform in reducing drug development costs, which confirms the company's operational reliability within the precision medicine niche.

Pesaing Lantern Pharma Inc. (LTRN)

Bathi operasional EBITDA ArriVent BioPharma AVBP|BIAF - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|EFTR (effector.com) - Bathi operasional sadurunge amortisasi